119
Participants
Start Date
February 28, 2007
Primary Completion Date
July 31, 2013
Study Completion Date
September 30, 2013
Bevacizumab
Bevacizumab
University of Pittsburgh Medical Center, Pittsburgh
Center for Cancer and Blood Disorders, Bethesda
Peninsula Cancer Institute, Newport News
Cancer Care of Western North Carolina, Asheville
Spartanburg Regional Medical Center, Spartanburg
Northeast Georgia Medical Center, Gainesville
Florida Cancer Specialists, Fort Myers
Tennessee Oncology, PLLC, Nashville
Chattanooga Oncology Hematology Associates, Chattanooga
Family Cancer Center, Collierville
Consultants in Blood Disorders and Cancer, Louisville
Oncology Hematology Care, Cincinnati
Methodist Cancer Center, Omaha
Collaborators (1)
Genentech, Inc.
INDUSTRY
SCRI Development Innovations, LLC
OTHER